U

UCB Pharma

Biopharmaceuticals for neurology and immunology therapies

VIE Associate Scientist Intern

Bioprocess & BiomanufacturingUpdated on Nov 14
InternshipBraine-l'Alleud, BelgiumNo salary listed

About the Job

Requirements

  • A Master’s or PhD in Biological Sciences, engineering with a biotechnology orientation, Chemical Engineering, Virology, or a related domain is required.
  • Zero to three years of experience is required.
  • Prior laboratory experience manipulating cells or viral vectors is required.
  • Fluency in written and spoken English is required.
  • Applicants must be between 18 and 28 years old, hold the nationality of a European Economic Area member country, and must not have worked or lived in Belgium, where the assignment will take place.
  • Applicants with French nationality or dual nationality must comply with French national service obligations.
  • Applicants must have a clean criminal record.

Responsibilities

  • Contribute to the development and optimization of viral vector manufacturing processes using cell culture technologies and bioreactor systems.
  • Design, execute, analyze, and present experimental studies to improve process performance, scalability, and product quality for cell and gene therapies.
  • Apply digital technologies, data analytics, automation, and monitoring tools to support process innovation and data-driven decision-making.
  • Collaborate with multidisciplinary Research and Manufacturing teams to translate scientific innovations into robust manufacturing solutions.
  • Develop technical and professional skills while gaining exposure to bioprocess development and quality-focused manufacturing.

About the Company

UCB Pharma

Biopharmaceuticals for neurology and immunology therapies

UCB Pharma focuses on developing treatments for severe diseases in neurology and immunology. It discovers, develops, and commercializes novel molecules and generates products aimed at improving patient lives. The company works by researching and developing therapies, integrating patient insights to guide innovation, and investing over a quarter of revenue into scientific research. Its global presence (about 9,000 employees across 40 countries) and €5.3 billion 2023 revenue reflect its scale and commitment to bringing therapies to patients worldwide. UCB differentiates itself by combining direct patient engagement with substantial R&D investment to address unmet needs in neurology and immunology, aiming to transform lives through science and patient care.

Company size
10,001+
Company stage
IPO
Headquarters
City of Brussels, Belgium
Founded
1928

Recently Posted Jobs

Explore more opportunities at UCB Pharma

See more jobs